Both in Pharmaceuticals
Janux Therapeutics vs MoonLake Immunotherapeutics
Over the past year JANX returned −32.7% and MLTX returned +14.1%; their daily moves had a correlation of 0.19.
JANX −32.7% MLTX +14.1%Growth of $1, one year, split-adjusted
| Metric | JANX | MLTX |
|---|---|---|
| Price | $18.18 | $11.56 |
| Market cap | $1.11B | $983.8M |
| Today | +2.02% | −1.20% |
| 1 month | +8.3% | +5.6% |
| 6 months | +24.4% | −34.7% |
| Year to date | +31.7% | −12.3% |
| 1 year | −33.6% | +13.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −214.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 46.3× | — |
| Net cash | $970.9M | $437.5M |
| Dividend yield | — | — |
| Volatility (60d) | 47.8% | 57.0% |
| Short % of float | 11.8% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).